Bethesda North TriHealth Hospital
Cincinnati, Ohio, 45242, United States
NCT Number: NCT03195881
This study investigates the relationship between optic nerve sheath diameter and increased intracranial pressure and its effect on neurologic outcome in post-cardiopulmonary arrest patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Cincinnati, Ohio, 45242, United States
This study involves patients who have experienced either an in-hospital or out-of-hospital cardiopulmonary arrest, and who meet the 2015 American Heart Association (AHA) inclusion/exclusion criteria for targeted temperature management [i.e., they are comatose or exhibit no meaningful response to verbal commands with return of spontaneous circulation (ROSC) after cardiac arrest]. After induction of hypothermia protocol after cardiopulmonary arrest (i.e., targeted temperature management), patients will undergo ocular ultrasound at three time points.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Post-cardiopulmonary arrest patients meeting inclusion/exclusion criteria for targeted temperature management will undergo ocular ultrasound at three time points: within 6 hours (h) of initiation of hypothermic protocol, between 10-24 h after hypothermic protocol initiation, and between 24-36 h after hypothermic protocol initiation.
Time frame: 0-6 hours after hypothermic protocol initiation
Optic nerve sheath diameter within 6 hours of hypothermic protocol initiation
Time frame: 10-24 hours after hypothermic protocol initiation
Optic nerve sheath diameter 10-24 hours after hypothermic protocol initiation
Time frame: 24-36 hours after hypothermic protocol initiation
Optic nerve sheath diameter 24-36 hours after hypothermic protocol initiation
Time frame: Through day 2
Measure of degree of disability or dependence in daily activities on day of informed consent
Time frame: Through 6 weeks
Measure of degree of disability or dependence in daily activities on day of discharge from ICU'
Time frame: Up to 26 weeks
Measure of degree of disability or dependence in daily activities six months after discharge from ICU
Time frame: Through day 2
Measure of neurologic outcome following cardiac arrest on day of informed consent
Time frame: Through 6 weeks
Measure of neurologic outcome following cardiac arrest on day of discharge from ICU
Time frame: Up to 26 weeks
Measure of neurologic outcome following cardiac arrest six months after discharge from ICU
TriHealth Inc.
Other
Post Cardiac Arrest Neuroprognostication Using the Diameter of Optic Nerve Sheath Via Ocular ultRAsound
Acronym: PANDORA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02007499
Cardiac Arrest, Cardiopulmonary Arrest
Milwaukee, Wisconsin, United States
View Trial DetailsNCT02555254
Body Temperature Changes, Cardiac Arrest
La Roche-sur-Yon, France
View Trial DetailsNCT05646875
Brain Diseases, Brain Injuries
Edegem, Belgium
View Trial DetailsNCT05316779
Anesthesia, Cardiovascular Diseases
Bern, Switzerland
View Trial Details